Borgo San Dalmazzo, Italy

Tommaso Boi

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Bracco Imaging S.p.a.. Active years: 2019-2020.


% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2019-2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Tommaso Boi

Introduction

Tommaso Boi is a notable inventor based in Borgo San Dalmazzo, Italy. He has made significant contributions to the field of chemistry, particularly in the preparation of hyperpolarized carboxylate compounds. With a total of two patents to his name, Boi's work is recognized for its potential applications in diagnostic imaging.

Latest Patents

Tommaso Boi's latest patents include a process for the preparation of hyperpolarized carboxylate compounds. This invention relates to a method for creating aqueous solutions of [1-C]-hyperpolarized carboxylate molecules that are of diagnostic interest. The process involves parahydrogenating unsaturated alkenyl or alkynyl esters of the concerned carboxylate molecules with molecular parahydrogen. This innovative approach enhances the utility of these compounds in medical diagnostics.

Career Highlights

Boi is currently employed at Bracco Imaging S.p.a., a company known for its advancements in medical imaging technologies. His work at Bracco Imaging has allowed him to focus on developing new methods that improve diagnostic capabilities. His contributions are vital in the ongoing evolution of imaging techniques.

Collaborations

Tommaso Boi collaborates with esteemed colleagues such as Silvio Aime and Erika Cerutti. These partnerships enhance the research and development efforts within the field, fostering innovation and progress.

Conclusion

Tommaso Boi's work exemplifies the intersection of innovation and practical application in the field of chemistry. His patents and collaborations contribute significantly to advancements in medical diagnostics.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…